These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 24197277)
41. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma. Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of IL-10 and TGF-β levels and myeloid and lymphoid dendritic cells in ovarian cancer patients. Wertel I; Polak G; Tarkowski R; Kotarska M Ginekol Pol; 2011 Jun; 82(6):414-20. PubMed ID: 21853929 [TBL] [Abstract][Full Text] [Related]
43. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Ataseven B; du Bois A; Reinthaller A; Traut A; Heitz F; Aust S; Prader S; Polterauer S; Harter P; Grimm C Gynecol Oncol; 2015 Sep; 138(3):560-5. PubMed ID: 26163893 [TBL] [Abstract][Full Text] [Related]
44. Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer. Zwakman N; van de Laar R; Van Gorp T; Zusterzeel PL; Snijders MP; Ferreira I; Massuger LF; Kruitwagen RF J Gynecol Oncol; 2017 Jan; 28(1):e7. PubMed ID: 27670261 [TBL] [Abstract][Full Text] [Related]
45. [The diagnostic and prognostic values of assay of serum vascular endothelial growth factor in epithelial ovarian cancer]. Tan X; Shen K; Liu D; Xu X; Lang J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Aug; 22(4):352-5. PubMed ID: 12903449 [TBL] [Abstract][Full Text] [Related]
46. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737 [TBL] [Abstract][Full Text] [Related]
47. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival. Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495 [TBL] [Abstract][Full Text] [Related]
48. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer. Li T; Xue H; Guo Y; Guo K Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of serum CCL18 as a potential biomarker for ovarian cancer. Yuan L; Wan J; Huang C; Liang J; Liu M; Yue C; Li L Cancer Biomark; 2017 Dec; 21(1):97-104. PubMed ID: 29036787 [TBL] [Abstract][Full Text] [Related]
50. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. Kim DK; Oh SY; Kwon HC; Lee S; Kwon KA; Kim BG; Kim SG; Kim SH; Jang JS; Kim MC; Kim KH; Han JY; Kim HJ BMC Cancer; 2009 May; 9():155. PubMed ID: 19457231 [TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer. Paek J; Lee SH; Yim GW; Lee M; Kim YJ; Nam EJ; Kim SW; Kim YT Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):338-42. PubMed ID: 21683503 [TBL] [Abstract][Full Text] [Related]
53. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer]. Yang HM; Lou G Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896 [No Abstract] [Full Text] [Related]
54. Prognostic significance of serum soluble CD163 level in patients with epithelial ovarian cancer. No JH; Moon JM; Kim K; Kim YB Gynecol Obstet Invest; 2013; 75(4):263-7. PubMed ID: 23595052 [TBL] [Abstract][Full Text] [Related]
55. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839 [TBL] [Abstract][Full Text] [Related]
56. KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis. Huang L; Zhou Y; Cao XP; Lin JX; Zhang L; Huang ST; Zheng M Tumour Biol; 2017 Jun; 39(6):1010428317706289. PubMed ID: 28651492 [TBL] [Abstract][Full Text] [Related]
57. Expression of Gab1 Is Associated with Poor Prognosis of Patients with Epithelial Ovarian Cancer. Hu L; Liu R Tohoku J Exp Med; 2016 Jul; 239(3):177-84. PubMed ID: 27302321 [TBL] [Abstract][Full Text] [Related]
58. Clinical significance of serum transforming growth factor-beta 1 (TGF-β1) levels in patients with epithelial ovarian cancer. Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D Tumour Biol; 2014 Apr; 35(4):3611-6. PubMed ID: 24310505 [TBL] [Abstract][Full Text] [Related]
59. Long non-coding RNA CPS1-IT1 is a positive prognostic factor and inhibits epithelial ovarian cancer tumorigenesis. Wang YS; Ma LN; Sun JX; Liu N; Wang H Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3169-3175. PubMed ID: 28770969 [TBL] [Abstract][Full Text] [Related]
60. Prognostic Value of Serum Creatinine Levels in Patients with Epithelial Ovarian Cancer. Lafleur J; Hefler-Frischmuth K; Grimm C; Schwameis R; Gensthaler L; Reiser E; Hefler LA Anticancer Res; 2018 Sep; 38(9):5127-5130. PubMed ID: 30194159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]